6039

Yifeng Pharmacy Chain Stock Price

Symbol: SHSE:603939Market Cap: CN¥29.4bCategory: Consumer Retailing

603939 Share Price Performance

CN¥24.21
1.41 (6.18%)
CN¥24.21
1.41 (6.18%)
Price CN¥24.21

603939 Community Narratives

There are no narratives available yet.

Community Fair Values

    Recent 603939 News & Updates

    No updates

    Yifeng Pharmacy Chain Co., Ltd. Key Details

    CN¥24.1b

    Revenue

    CN¥14.5b

    Cost of Revenue

    CN¥9.6b

    Gross Profit

    CN¥8.0b

    Other Expenses

    CN¥1.6b

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    Aug 29, 2025
    Earnings per share (EPS)
    1.30
    Gross Margin
    39.87%
    Net Profit Margin
    6.52%
    Debt/Equity Ratio
    24.5%

    Yifeng Pharmacy Chain Co., Ltd. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 603939

    Founded
    2001
    Employees
    40018
    CEO
    Gao Yi
    WebsiteView website
    www.yfdyf.cn

    Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. The company is also involved in chronic disease management, medical project investment, and medical technology development, as well as operates internet hospitals. It also offers its products through franchise distribution and e-commerce. Yifeng Pharmacy Chain Co., Ltd. was founded in 2001 and is headquartered in Changsha, China.

    Chinese Market Performance

    • 7 Days: -1.1%
    • 3 Months: 10.9%
    • 1 Year: 30.1%
    • Year to Date: 11.3%
    Over the last 7 days, the market has dropped 1.1%, driven by a decline of 1.9% in the Industrials sector. In contrast to the last week, the market is actually up 30% over the past year. Earnings are forecast to grow by 24% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading